Cargando…

Up-Regulating CYP3A4 Expression in C3A Cells by Transfection with a Novel Chimeric Regulator of hPXR-p53-AD

Most hepatoma cell lines lack proper expression and induction of CYP3A4 enzyme, which limits their use for predicting drug metabolism and toxicity. Nuclear receptor pregnane X receptor (PXR) has been well recognized for its critical role in regulating expression of CYP3A4 gene. However, its physiolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Feng, Rao, Xiao-Hui, Yang, Jin-Lian, Pan, Ming-Xing, Gao, Yi, Li, Zhen-Lin, Li, Yang, Zhu, You-Fu, Wang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006776/
https://www.ncbi.nlm.nih.gov/pubmed/24788541
http://dx.doi.org/10.1371/journal.pone.0095752
_version_ 1782314259641794560
author Chen, Feng
Rao, Xiao-Hui
Yang, Jin-Lian
Pan, Ming-Xing
Gao, Yi
Li, Zhen-Lin
Li, Yang
Zhu, You-Fu
Wang, Yan
author_facet Chen, Feng
Rao, Xiao-Hui
Yang, Jin-Lian
Pan, Ming-Xing
Gao, Yi
Li, Zhen-Lin
Li, Yang
Zhu, You-Fu
Wang, Yan
author_sort Chen, Feng
collection PubMed
description Most hepatoma cell lines lack proper expression and induction of CYP3A4 enzyme, which limits their use for predicting drug metabolism and toxicity. Nuclear receptor pregnane X receptor (PXR) has been well recognized for its critical role in regulating expression of CYP3A4 gene. However, its physiological activity of binding to the particular site of promoter is significantly weakened in hepatic cell lines. To address this problem, we created “chimeric PXR” constructs by appending a strong activation domain (AD) from p53 subunit to either N- or C- termini of the human PXR (hPXR), that is, hPXR-p53 and p53-hPXR. C3A, a hepatoma cell line, was used as the cell model to test the regulation effect of chimeric hPXR over wild type (WT) hPXR on CYP3A4 expression at gene, protein, and metabolism levels, respectively. Compared with C3A cells transiently transfected with WT hPXR, the activity of CYP3A4.XREM.luc reporter gene in C3A cells transfected with hPXR-p53 or p53-hPXR increased 5- and 9-fold respectively, and the levels of CYP3A4 mRNA expression increased 3.5- and 2.6-fold, respectively. C3A cells stably transfected with hPXR-p53-AD exhibited an improved expression of CYP3A4 at both gene (2-fold) and protein (1.5-fold) levels compared to WT C3A cells. Testosterone, a CYP3A4-specific substrate, was used for detecting the metabolism activity of CYP3A4. No testosterone metabolite could be detected in microsomes from WT C3A cells and WT C3A cells-based array, while the formation of 6β-hydroxytestosterone metabolite in the transfected cells was 714 and 55 pmol/mg protein/min, respectively. In addition, all the above expression levels in the transfected cell models could be further induced with additional treatment of Rifampicin, a specific inducer for CYP3A4. In conclusion, our study established a proof-of-principle example that genetic modification with chimeric hPXR-p53-AD could improve CYP3A4 metabolism ability in hepatic cell line.
format Online
Article
Text
id pubmed-4006776
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-40067762014-05-09 Up-Regulating CYP3A4 Expression in C3A Cells by Transfection with a Novel Chimeric Regulator of hPXR-p53-AD Chen, Feng Rao, Xiao-Hui Yang, Jin-Lian Pan, Ming-Xing Gao, Yi Li, Zhen-Lin Li, Yang Zhu, You-Fu Wang, Yan PLoS One Research Article Most hepatoma cell lines lack proper expression and induction of CYP3A4 enzyme, which limits their use for predicting drug metabolism and toxicity. Nuclear receptor pregnane X receptor (PXR) has been well recognized for its critical role in regulating expression of CYP3A4 gene. However, its physiological activity of binding to the particular site of promoter is significantly weakened in hepatic cell lines. To address this problem, we created “chimeric PXR” constructs by appending a strong activation domain (AD) from p53 subunit to either N- or C- termini of the human PXR (hPXR), that is, hPXR-p53 and p53-hPXR. C3A, a hepatoma cell line, was used as the cell model to test the regulation effect of chimeric hPXR over wild type (WT) hPXR on CYP3A4 expression at gene, protein, and metabolism levels, respectively. Compared with C3A cells transiently transfected with WT hPXR, the activity of CYP3A4.XREM.luc reporter gene in C3A cells transfected with hPXR-p53 or p53-hPXR increased 5- and 9-fold respectively, and the levels of CYP3A4 mRNA expression increased 3.5- and 2.6-fold, respectively. C3A cells stably transfected with hPXR-p53-AD exhibited an improved expression of CYP3A4 at both gene (2-fold) and protein (1.5-fold) levels compared to WT C3A cells. Testosterone, a CYP3A4-specific substrate, was used for detecting the metabolism activity of CYP3A4. No testosterone metabolite could be detected in microsomes from WT C3A cells and WT C3A cells-based array, while the formation of 6β-hydroxytestosterone metabolite in the transfected cells was 714 and 55 pmol/mg protein/min, respectively. In addition, all the above expression levels in the transfected cell models could be further induced with additional treatment of Rifampicin, a specific inducer for CYP3A4. In conclusion, our study established a proof-of-principle example that genetic modification with chimeric hPXR-p53-AD could improve CYP3A4 metabolism ability in hepatic cell line. Public Library of Science 2014-05-01 /pmc/articles/PMC4006776/ /pubmed/24788541 http://dx.doi.org/10.1371/journal.pone.0095752 Text en © 2014 Chen et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Chen, Feng
Rao, Xiao-Hui
Yang, Jin-Lian
Pan, Ming-Xing
Gao, Yi
Li, Zhen-Lin
Li, Yang
Zhu, You-Fu
Wang, Yan
Up-Regulating CYP3A4 Expression in C3A Cells by Transfection with a Novel Chimeric Regulator of hPXR-p53-AD
title Up-Regulating CYP3A4 Expression in C3A Cells by Transfection with a Novel Chimeric Regulator of hPXR-p53-AD
title_full Up-Regulating CYP3A4 Expression in C3A Cells by Transfection with a Novel Chimeric Regulator of hPXR-p53-AD
title_fullStr Up-Regulating CYP3A4 Expression in C3A Cells by Transfection with a Novel Chimeric Regulator of hPXR-p53-AD
title_full_unstemmed Up-Regulating CYP3A4 Expression in C3A Cells by Transfection with a Novel Chimeric Regulator of hPXR-p53-AD
title_short Up-Regulating CYP3A4 Expression in C3A Cells by Transfection with a Novel Chimeric Regulator of hPXR-p53-AD
title_sort up-regulating cyp3a4 expression in c3a cells by transfection with a novel chimeric regulator of hpxr-p53-ad
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006776/
https://www.ncbi.nlm.nih.gov/pubmed/24788541
http://dx.doi.org/10.1371/journal.pone.0095752
work_keys_str_mv AT chenfeng upregulatingcyp3a4expressioninc3acellsbytransfectionwithanovelchimericregulatorofhpxrp53ad
AT raoxiaohui upregulatingcyp3a4expressioninc3acellsbytransfectionwithanovelchimericregulatorofhpxrp53ad
AT yangjinlian upregulatingcyp3a4expressioninc3acellsbytransfectionwithanovelchimericregulatorofhpxrp53ad
AT panmingxing upregulatingcyp3a4expressioninc3acellsbytransfectionwithanovelchimericregulatorofhpxrp53ad
AT gaoyi upregulatingcyp3a4expressioninc3acellsbytransfectionwithanovelchimericregulatorofhpxrp53ad
AT lizhenlin upregulatingcyp3a4expressioninc3acellsbytransfectionwithanovelchimericregulatorofhpxrp53ad
AT liyang upregulatingcyp3a4expressioninc3acellsbytransfectionwithanovelchimericregulatorofhpxrp53ad
AT zhuyoufu upregulatingcyp3a4expressioninc3acellsbytransfectionwithanovelchimericregulatorofhpxrp53ad
AT wangyan upregulatingcyp3a4expressioninc3acellsbytransfectionwithanovelchimericregulatorofhpxrp53ad